{ "results": [ { "id": "d9dd77bba2763c86b4e97f912ac69625", "title": "Scientist II, Animal Model Development", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Frederick, MD", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 70000, "salary_max": 120000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 70000, "base_salary_max": 120000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-05T14:33:38.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 7, "role_function": "sales", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.04969d7025eed0ae0e", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.20c15d8542ec708965", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.51b94a55584759d54b", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.53f701ef0f5625c851", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a0f0a6122f9332e3e5", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.eed3bf7c4c7bc0a282", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.2900a63f370f40bb4b", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:32084aff23f595f05bf49d64", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2f858ae5a1ed2bb039", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.516297a6797d0f7969", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.97d5a87038a0f881bb", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.5dbdf33779f07ea357", "query_id": "gq_8b028d475e507d74290a", "job_id": "d9dd77bba2763c86b4e97f912ac69625", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "sales", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:d9dd77bba2763c86b4e97f912ac69625:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "dead2e586561377764f2a1fe30e9a500", "title": "Senior Specialist, Regulatory Operations", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Frederick, MD", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 70000, "salary_max": 130000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 70000, "base_salary_max": 130000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-01-15T15:31:52.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Specialist, Regulatory Operations Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Specialist, Regulatory Operations, will", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 9, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 10, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.3d9c3ce939c8fc2a9a", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Specialist, Regulatory Operations Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Specialist, Regulatory Operations, will", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.7b94b8b1c83343a1b6", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Specialist, Regulatory Operations Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Specialist, Regulatory Operations, will", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0a0d8dbd80177acbf5", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.378dbf51a58218ecf2", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.58a095a43dc5a083b3", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.63375b9e1700657cf7", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.55a1f6e998d7498d28", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:2eefde2aba755c83b14c9711", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.20d0ad58c195f6bd22", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.60e3bcaa89bcf1eb37", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d62b5d2b0bbda12c42", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.558eac0100ba070a77", "query_id": "gq_8b028d475e507d74290a", "job_id": "dead2e586561377764f2a1fe30e9a500", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:dead2e586561377764f2a1fe30e9a500:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "title": "Postdoctoral Fellowship-Immunology", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Frederick, MD 21701", "country": "unknown", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 3, "salary_min": 75000, "salary_max": 95000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 75000, "base_salary_max": 95000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-18T14:37:47.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Postdoctoral Fellowship-Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking a highly motivated and", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 7, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0d78c3f52857a32246", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Postdoctoral Fellowship-Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking a highly motivated and", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.90bc0a8057c9241381", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Postdoctoral Fellowship-Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking a highly motivated and", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0d3e6b2eab0b0e13cd", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.41575c68da1a050925", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cf5f43676e88830b16", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f767f55b07feb6f23e", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.66874e74c4d0b84c35", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:b4ccc4a7ab6275fdc41924b4", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2a07fef41efc234696", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3cbfc61dcefaeb42ec", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.503a0609ef86aad06a", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.e44a299265536193bc", "query_id": "gq_8b028d475e507d74290a", "job_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f0ce14bd47d44c234dc4d1bfb2dda4fa:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245264009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "title": "Pharmacovigilance Scientist", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 124000, "salary_max": 170000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 124000, "base_salary_max": 170000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-02T15:00:03.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Pharmacovigilance Scientist Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an experienced Pharmacovigilance Scientist", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 7, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0183a3c5cbeaebdb51", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Pharmacovigilance Scientist Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an experienced Pharmacovigilance Scientist", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c5d461246a17b86e45", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Pharmacovigilance Scientist Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an experienced Pharmacovigilance Scientist", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.21d39ee2c941e4b133", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.395341c37e15de7774", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.484abd1bc9732fa1ad", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fd8eaf08d80bcd13ce", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.02c2452af78712dbfa", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:6a4bb7d07a75d0bdd9b061c8", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1e1421619fdb56e708", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.338c5a8844680fe76a", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.cd4c93f7e47cc4016e", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.2f8a1a444249a614d8", "query_id": "gq_8b028d475e507d74290a", "job_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:68bb3e89493f97efe7d4b0ce5fd3e5e1:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "a771ce567d3aa976d8a681c6f9939324", "title": "Thought Leader Liaison (TLL), West Region", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "United States", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 130000, "salary_max": 200000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 130000, "base_salary_max": 200000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-02-12T16:46:05.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Thought Leader Liaison (TLL), West Region United States Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Director, Thought", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 7, "role_function": "marketing", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 75, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.105d2642ab53146a17", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Thought Leader Liaison (TLL), West Region United States Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Director, Thought", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.1f5e5d38a2c1a94290", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Thought Leader Liaison (TLL), West Region United States Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Director, Thought", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.04aabca455ab44b2fa", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2e3f91b614fe447b20", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.4f6959b236f74f183a", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.98beaa4e7409feb8e8", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.7581ca146646f34b49", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:77d0b2d8aeef20fccc91e261", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.618714e9ee5c0da725", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6f86ec2762d95d8afa", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.de36a5c5e59707e714", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.4f9dc5ec19cc8be687", "query_id": "gq_8b028d475e507d74290a", "job_id": "a771ce567d3aa976d8a681c6f9939324", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "marketing", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a771ce567d3aa976d8a681c6f9939324:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "3c24ac7bb567169977728f315265cb92", "title": "Associate Director, Regulatory Affairs", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA or Fort Worth, TX", "country": "US", "employment_type": "full_time", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 190000, "salary_max": 200000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 190000, "base_salary_max": 200000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-14T13:12:19.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, Regulatory Affairs Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA or Fort Worth, TX Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.15b3549bad0bd548ca", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Regulatory Affairs Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA or Fort Worth, TX Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.5cf9f8b7b849d0ff6f", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Director, Regulatory Affairs Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA or Fort Worth, TX Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.180a52b8567f45bacb", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.47730c0ad3b07ad2e0", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6c5869b80176f9e7d2", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d37d73c6c54bb2561c", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.b0bf25503267300369", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:13ea58e3b32ff74a5d376998", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2d085ab8f84fcaf552", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.756d4be43f806ab5c3", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c37a3f31acfeaf324f", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.37b3f81c8f949324ad", "query_id": "gq_8b028d475e507d74290a", "job_id": "3c24ac7bb567169977728f315265cb92", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:3c24ac7bb567169977728f315265cb92:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4215536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "43c521ed362b3cbb500a34ca41435de7", "title": "Sr. Director, Brand Marketing", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 190000, "salary_max": 285000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 190000, "base_salary_max": 285000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-24T12:36:50.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Sr. Director, Brand Marketing Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Director, Brand Marketing", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "marketing", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.82bfd0f568b1390ebc", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Sr. Director, Brand Marketing Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Director, Brand Marketing", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.f6ec1801a56c97f788", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Sr. Director, Brand Marketing Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Director, Brand Marketing", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1a3ef1a7300204783c", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.83d7e260ab5f1299fa", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9c3e8449f31dc3a2ac", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bfcc0b52a5868e034f", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.3f348381735c586b6d", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:b817bc90f15e653dfa660169", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.77b2a9651ff5965a47", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7fd4695398b2e8482a", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.f93f172babc9492b85", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.1564a7e630e0495c3d", "query_id": "gq_8b028d475e507d74290a", "job_id": "43c521ed362b3cbb500a34ca41435de7", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "marketing", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:43c521ed362b3cbb500a34ca41435de7:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "19f128092c2078d54205dc1b98eb6237", "title": "Senior Manager, Total Rewards", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 130000, "salary_max": 170000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 130000, "base_salary_max": 170000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-05T19:32:12.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Total Rewards Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Total Rewards", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "bonus_offered": { "field": "bonus_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "bonus_offered" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 9, "role_function": "hr", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c4d4b0d95724fe2690", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Total Rewards Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Total Rewards", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ef97b8d4d33256ea43", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Total Rewards Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Total Rewards", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.23788e843532dad199", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.2625f44d102f690e1d", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.5acd78502d9e47af2e", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.de1dc5f2b5bf16fcf4", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.52f0006f542a95bcc9", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:7b8e2fa9d12be8962414abd9", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.038aff41df2680eb9f", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.371b327dc1934f3f51", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bcf855a980154b1e29", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.96e1fd3a8a83b34028", "query_id": "gq_8b028d475e507d74290a", "job_id": "19f128092c2078d54205dc1b98eb6237", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "hr", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:19f128092c2078d54205dc1b98eb6237:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "076f9f44f246f0b540e082f0b12e48b8", "title": "Manager, Corporate Strategy and CEO Initiatives", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 90000, "salary_max": 150000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 90000, "base_salary_max": 150000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-06-04T15:41:23.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 7, "years_experience_max": null, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.049a934df81a1f3c51", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Description: \"corp\"", "tooltip": "Description matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:description:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.43119845a5a7e11c6b", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.578664c1ff6947bcfb", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3cda93ed789b0323d3", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.80b61155b1e89b1fdd", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e12933da2c96529833", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fc371397f74cbd03a5", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.title.347b39e4f020c9e4ad", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Title: \"corp\"", "tooltip": "Title matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "title", "source_value": "Manager, Corporate Strategy and CEO Initiatives", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:title:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.f50d9a7553b39cf303", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:41958c2f102092b1649cde66", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.39d504fc82ed2629e5", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.48a85817763e25a2b0", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e19ce12b09df5d7cce", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.5ecae445e2202e19bf", "query_id": "gq_8b028d475e507d74290a", "job_id": "076f9f44f246f0b540e082f0b12e48b8", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:076f9f44f246f0b540e082f0b12e48b8:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "1b326dea67a7a33623858526b1b4d5b5", "title": "Manager, Quality Systems & Administration", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "North Dartmouth, MA", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 110000, "salary_max": 145000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 110000, "base_salary_max": 145000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-13T18:42:00.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Manager, Quality Systems & Administration North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview: The Manager, Quality Systems", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 10, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.094cc272ef4c471d1f", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Quality Systems & Administration North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview: The Manager, Quality Systems", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.e618bd1eba584e965e", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Quality Systems & Administration North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview: The Manager, Quality Systems", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.21a9f0d0deac592f95", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.3c8101e248ee87839c", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9ce013237961e21e30", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ee5b22af766f783df1", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.883686020ed9d06a6b", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:a48705ed10deb56365b4bd66", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.54e1c1f192fd1dd2d8", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8e857effcec358c873", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.984617080c06025faa", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.c147359eebe864d874", "query_id": "gq_8b028d475e507d74290a", "job_id": "1b326dea67a7a33623858526b1b4d5b5", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:1b326dea67a7a33623858526b1b4d5b5:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "6445f086c535ac6e27d289212fcec87f", "title": "Associate Scientist I, Immunology", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Frederick, MD 21701", "country": "unknown", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 3, "salary_min": 50000, "salary_max": 70000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 50000, "base_salary_max": 70000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-18T14:29:33.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 3, "years_experience_max": 7, "role_function": "data", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c17ea5260c0f153efa", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.c3ab94c0942a12c099", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.154b3b867696742154", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.644564c1350e7b7ff3", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9e63400f4ec18440c2", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.c47039b787443d0ae8", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.1387590092726bd6d6", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:2386f80faffe6c1a57db5b29", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1a1f68f040a5ec6201", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.675d98298e0334a549", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.699646dc48a9a4faba", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.0135b46ff1fb2ebcc7", "query_id": "gq_8b028d475e507d74290a", "job_id": "6445f086c535ac6e27d289212fcec87f", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "data", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6445f086c535ac6e27d289212fcec87f:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "22eb7400d93a2228a5baebd96c302a3f", "title": "Senior Manager, Cost Accounting", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA", "country": "US", "employment_type": "contract", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 100000, "salary_max": 150000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 100000, "base_salary_max": 150000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-21T17:03:55.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "senior", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 9, "role_function": "finance", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.419ae67c688d275757", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.de88311655a397964e", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8cd662fe455113de40", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.93ad6b815e5e4d3523", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a2e31c56334511a32a", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.dc81491b14b17ddf17", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.e4366421f2fe5eeb30", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:2a04c02069e1b9e1a1b202d1", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.231ecb8525b8eb9eaf", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7a5620561a1047ab30", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.fdef33f98dec2842df", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.026ba6da27c3dfa6a8", "query_id": "gq_8b028d475e507d74290a", "job_id": "22eb7400d93a2228a5baebd96c302a3f", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "finance", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:22eb7400d93a2228a5baebd96c302a3f:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "f06685f8e74b0dfbf35a29a875ace009", "title": "Senior Director of CMC and Nonclinical Program Management", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "North Dartmouth, MA", "country": "US", "employment_type": "contract", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 223814, "salary_max": 279767, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 223814, "base_salary_max": 279767, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-19T21:12:55.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Director of CMC and Nonclinical Program Management North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0bc74639352e261f01", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director of CMC and Nonclinical Program Management North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.f66e3464e5fd475867", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Senior Director of CMC and Nonclinical Program Management North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1f0b31b178b21f5759", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.60d8fda81d7069b8d5", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.891530b02f3e63839e", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8ff9103d0975d625c3", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.e8f4190e016371dc2f", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:b71e8221a3d852d9978250b3", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.523820d38dc38a7791", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.9beb9ec9bd340be194", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e83f4639e71a1a4593", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.3a996b5f19a9cd38f7", "query_id": "gq_8b028d475e507d74290a", "job_id": "f06685f8e74b0dfbf35a29a875ace009", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:f06685f8e74b0dfbf35a29a875ace009:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "256f7ef8e33d2e98558295760474e478", "title": "Manager, Trade & Market Access", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "contract", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 90000, "salary_max": 150000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 90000, "base_salary_max": 150000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-05T16:49:40.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "mid", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 5, "years_experience_max": 9, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.5adc988f645c626e01", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.af0bf70288314d3f00", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1d908d3f686ae9a4dd", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.508f00873e3cba94e6", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.8c78976087b8de2c9c", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ab8a94f6d1eb3bdd88", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.de6c4812ac7d47700b", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:a2849e2ccc536c90c1809b7c", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.08f47dfa8370e96918", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.7002fb8e3fc74b331d", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d730fa7d6a51011d13", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.9d8b2120bf4bb12976", "query_id": "gq_8b028d475e507d74290a", "job_id": "256f7ef8e33d2e98558295760474e478", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:256f7ef8e33d2e98558295760474e478:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "5c6b235f210f6bca2c418a52d210c197", "title": "Director, Commercial Operations and Analytics", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 180000, "salary_max": 230000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 180000, "base_salary_max": 230000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2025-12-15T20:32:13.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Commercial Operations and Analytics Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Commercial Operations", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "tech_stack": { "field": "tech_stack", "source": "llm:greenfield:inv_371_postfix", "db_column": "tech_stack" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": null, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "masters", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.6e835122aa45a4f98f", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Commercial Operations and Analytics Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Commercial Operations", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.ceb77eaa907d1ad359", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Commercial Operations and Analytics Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Commercial Operations", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b05225826a5a34bd85", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.bc23a1cdb0ef1e8dba", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.e4e5cac4c57babd120", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ea8cde59fb8d8bdf1f", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.c565bb3f16961f672a", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:1ad3b8ee5ffd7929db5930dd", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.05afd6df7482315540", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.38b37bdf696c069967", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b41cb14a62a5449f07", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.5cc2ac945964fb4c75", "query_id": "gq_8b028d475e507d74290a", "job_id": "5c6b235f210f6bca2c418a52d210c197", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5c6b235f210f6bca2c418a52d210c197:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "7889073eeed97ffb0af8f3c7a5a54399", "title": "VP, Clinical Development - Infectious Disease", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Frederick, Maryland or Berkeley Heights, New Jersey", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 250000, "salary_max": 350000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 250000, "base_salary_max": 350000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-01-20T21:03:17.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "VP, Clinical Development - Infectious Disease Frederick, Maryland or Berkeley Heights, New Jersey Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": null, "role_function": "healthcare", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.09c721f1a86a0982c8", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "VP, Clinical Development - Infectious Disease Frederick, Maryland or Berkeley Heights, New Jersey Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.31afa0494d29b4d03c", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "VP, Clinical Development - Infectious Disease Frederick, Maryland or Berkeley Heights, New Jersey Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.1f8e2d3cf57adc819c", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.37bcaf48135a23f53d", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.5224ea06e73fe611f6", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.64fc084eb4e4fb9a97", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.09a1f2aaec607edb49", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:6f41fdb14280e663debb3679", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ab02e22af80aed7f3d", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.add2063ccb6565c605", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.ee4b8623299f77e402", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.699a2847488ab0886b", "query_id": "gq_8b028d475e507d74290a", "job_id": "7889073eeed97ffb0af8f3c7a5a54399", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "healthcare", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:7889073eeed97ffb0af8f3c7a5a54399:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "79078570025ba379266174208ccd6737", "title": "Director, Regulatory Affairs - Infectious Disease", "employer_name": "Tonix Pharmaceuticals Holding Corp", "employer_slug": "tonix-pharmaceuticals-holding", "location_text": "Berkeley Heights, NJ", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 150000, "salary_max": 240000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 150000, "base_salary_max": 240000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-03-11T18:51:58.000Z", "apply_url": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Regulatory Affairs - Infectious Disease Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Regulatory", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 12, "years_experience_max": 12, "role_function": "operations", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": 20, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.b2ce86d1ba1f10c5a7", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Regulatory Affairs - Infectious Disease Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Regulatory", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.f1bc7d2b77d1b2e95f", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Description: \"tonix\"", "tooltip": "Description matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, Regulatory Affairs - Infectious Disease Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Regulatory", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:description:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.0a1922558f1aaff7cf", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.29131aa9bd7c1cc4c4", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b155e972509ce205e4", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer matched \"tonix\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:employer:tonix", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.b8f121acc37634de30", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:employer:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.ab2fe96eee6eb990c9", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:a8999c058584696374a6d955", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.06a174a57f5c0e5374", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"tonix\"", "tooltip": "Employer contains \"tonix\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "tonix", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.89ad53a326cc0463ec", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.eb2d5cbdb0301ae9bf", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Tonix Pharmaceuticals Holding Corp", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.9a6772189ff5218da1", "query_id": "gq_8b028d475e507d74290a", "job_id": "79078570025ba379266174208ccd6737", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "operations", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:79078570025ba379266174208ccd6737:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1430306/000199937126005730/tnxp-10k_123125.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "a0435b45c52a184adae206b9577d6328", "title": "Director, Investor Relations", "employer_name": "Amylyx Pharmaceuticals Inc", "employer_slug": "amylyx-pharmaceuticals", "location_text": "Cambridge, MA", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 204000, "salary_max": 230000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 204000, "base_salary_max": 230000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-26T15:24:10.000Z", "apply_url": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Investor Relations Cambridge, MA Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine's toughest problems, we encourage you to read the opportunity below and apply. The Opportunity Join Amylyx at a pivotal moment of growth and visibility as our Director, Investor Relations -a high-impact role at the center of our corporate story, strategy, and market presence. In this position, you'll work side-by-side with the VP of Investor Relations & Communications and partner closely with our senior leadership team-including our co-CEOs, CFO, CMO, and CCO-to shape how the investment community understands and values our mission. You'll serve as a strategic advisor and storyteller, helping to translate complex science and financial performance into a clear, compelling narrative that resonates with investors and analysts. You'll play a key role in strengthening our investor engagement program, building meaningful relationships, and influencing how Amylyx", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": null, "role_function": "finance", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.2c6df5a7fadc279329", "query_id": "gq_8b028d475e507d74290a", "job_id": "a0435b45c52a184adae206b9577d6328", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Amylyx Pharmaceuticals Inc", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:7e76b9b9a1298678302c85a8", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.0816c77253c1f8f754", "query_id": "gq_8b028d475e507d74290a", "job_id": "a0435b45c52a184adae206b9577d6328", "signal_type": "query_match", "display_text": "Description: \"corp\"", "tooltip": "Description contains \"corp\" from your search.", "source_binding": "token_match", "source_field": "description_excerpt", "source_value": "Director, Investor Relations Cambridge, MA Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine's toughest problems, we encourage you to read the opportunity below and apply. The Opportunity Join Amylyx at a pivotal moment of growth and visibility as our Director, Investor Relations -a high-impact role at the center of our corporate story, strategy, and market presence. In this position, you'll work side-by-side with the VP of Investor Relations & Communications and partner closely with our senior leadership team-including our co-CEOs, CFO, CMO, and CCO-to shape how the investment community understands and values our mission. You'll serve as a strategic advisor and storyteller, helping to translate complex science and financial performance into a clear, compelling narrative that resonates with investors and analysts. You'll play a key role in strengthening our investor engagement program, building meaningful relationships, and influencing how Amylyx", "matched_input": "corp", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a345d8b01ec64eb9ae", "query_id": "gq_8b028d475e507d74290a", "job_id": "a0435b45c52a184adae206b9577d6328", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Amylyx Pharmaceuticals Inc", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.8c37b7d6c2be9f67a3", "query_id": "gq_8b028d475e507d74290a", "job_id": "a0435b45c52a184adae206b9577d6328", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "finance", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:a0435b45c52a184adae206b9577d6328:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/6002934004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "5602c1f6ba651a74f09c99cb06b17a0a", "title": "Senior Vice President, Sales", "employer_name": "Amylyx Pharmaceuticals Inc", "employer_slug": "amylyx-pharmaceuticals", "location_text": "Flexible/ U.S. Based", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 353000, "salary_max": 397000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base_plus_commission", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 353000, "base_salary_max": 397000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": true, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-13T16:54:43.000Z", "apply_url": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Senior Vice President, Sales Flexible/ U.S. Based Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine's toughest problems, we encourage you to read the opportunity below and apply. The Opportunity The SVP of Sales will play a critical leadership role in building and executing the commercial strategy for a pre‑commercial biotechnology company preparing for its first product launch. This individual will be responsible for designing and implementing the Go‑To‑Market (GTM) strategy, recruiting and developing a high‑performing sales organization, establishing strong relationships with Key Opinion Leaders (KOLs), ensuring full sales force readiness ahead of launch and driving performance. We anticipate hiring the Senior Vice President, Sales in September 2026. The ideal candidate combines strategic vision with hands‑on execution experience in specialty pharma or biotech launches and thrives in a fast‑paced, build‑from‑scratch environment. Responsibilities Enterprise Commercial Leadership - Shape overall U.S. commercial", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "sales", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "doctorate", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.96bf580b72b5b3eccf", "query_id": "gq_8b028d475e507d74290a", "job_id": "5602c1f6ba651a74f09c99cb06b17a0a", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Amylyx Pharmaceuticals Inc", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:4116323366dddbc3337d6893", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d76c6dfd6ba79749a0", "query_id": "gq_8b028d475e507d74290a", "job_id": "5602c1f6ba651a74f09c99cb06b17a0a", "signal_type": "query_match", "display_text": "Employer: \"pharmaceuticals\"", "tooltip": "Employer contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Amylyx Pharmaceuticals Inc", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.818585bddc06571b3b", "query_id": "gq_8b028d475e507d74290a", "job_id": "5602c1f6ba651a74f09c99cb06b17a0a", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "sales", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:5602c1f6ba651a74f09c99cb06b17a0a:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1658551/000119312526086645/amlx-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://job-boards.greenhouse.io/amylyx/jobs/5994725004", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "8e771fd18cfcd3e69fa10b9e491e5693", "title": "Head of Pharmaceutical R&D PTDC-F", "employer_name": "Roche Holding AG", "employer_slug": "roche-holding", "location_text": "Basel, Basel-City, Switzerland", "country": "CH", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 3, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "UNSPECIFIED", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": false, "equity_included_source": null, "equity_type": [ "none" ], "k401_match": null, "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [], "k401_contribution_source_url": null, "k401_contribution_source_fields": [], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-02-13T00:00:00.000Z", "apply_url": "https://roche.wd3.myworkdayjobs.com/roche-ext/job/Basel/Head-of-Pharmaceutical-R-D-PTDC-F_202502-103969-1/apply", "apply_url_verified": false, "ats": "phenom_people", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Head of Pharmaceutical R&D PTDC-F Basel, Basel-City, Switzerland Join our team as the Head of Pharmaceutical R&D, where you will lead innovative drug development initiatives, ensuring regulatory compliance and driving scientific excellence. Collaborate with cross-functional teams to deliver impactful solutions that enhance patient care and advance healthcare globally.", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 40, "benefit_verified": false, "benefit_last_verified": null, "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "other", "role_function_source": "unknown", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 45, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.5a97e7906050fadf53", "query_id": "gq_8b028d475e507d74290a", "job_id": "8e771fd18cfcd3e69fa10b9e491e5693", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer matched \"holding\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Roche Holding AG", "matched_input": "holding", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:8e771fd18cfcd3e69fa10b9e491e5693:employer:holding", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.employer_name.8ed1fce77de024be91", "query_id": "gq_8b028d475e507d74290a", "job_id": "8e771fd18cfcd3e69fa10b9e491e5693", "signal_type": "query_match", "display_text": "Employer: semantic match", "tooltip": "Employer provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "employer_name", "source_value": "Roche Holding AG", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:4fbf4337961723903a0d6889", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.a2ef4d5f0cc1077810", "query_id": "gq_8b028d475e507d74290a", "job_id": "8e771fd18cfcd3e69fa10b9e491e5693", "signal_type": "query_match", "display_text": "Employer: \"holding\"", "tooltip": "Employer contains \"holding\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Roche Holding AG", "matched_input": "holding", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "parental_leave_source_label": null, "k401_match_source_label": null, "k401_contribution_source_label": null, "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "equity_included": { "tier": "inferred", "verified": false, "label": "Inferred - source not recorded", "source_label": "source not recorded", "href": null, "source_values": [], "checked_at": null }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://roche.wd3.myworkdayjobs.com/roche-ext/job/Basel/Head-of-Pharmaceutical-R-D-PTDC-F_202502-103969-1/apply", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null } } }, { "id": "043af6f70432ace1dc6c163b9c49f1d9", "title": "National Sales Director - Pharmaceuticals (Infectious Disease)", "employer_name": "Asahi Kasei Corp.", "employer_slug": "asahi-kasei", "location_text": "Remote Home Office USA", "country": "US", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": false, "equity_included_source": null, "equity_type": [ "none" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-27T00:00:00.000Z", "apply_url": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/National-Sales-Director---Pharmaceuticals--Infectious-Disease-_R5586-1", "apply_url_verified": false, "ats": "workday", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "National Sales Director - Pharmaceuticals (Infectious Disease) Remote Home Office USA posted: Posted 16 Days Ago", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "sales", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 35, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.04c80e1de9a02d01ab", "query_id": "gq_8b028d475e507d74290a", "job_id": "043af6f70432ace1dc6c163b9c49f1d9", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "National Sales Director - Pharmaceuticals (Infectious Disease) Remote Home Office USA posted: Posted 16 Days Ago", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:043af6f70432ace1dc6c163b9c49f1d9:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.69b58472e43feb9e8d", "query_id": "gq_8b028d475e507d74290a", "job_id": "043af6f70432ace1dc6c163b9c49f1d9", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Asahi Kasei Corp.", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:043af6f70432ace1dc6c163b9c49f1d9:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.title.4996448b7a536820cf", "query_id": "gq_8b028d475e507d74290a", "job_id": "043af6f70432ace1dc6c163b9c49f1d9", "signal_type": "query_match", "display_text": "Title: \"pharmaceuticals\"", "tooltip": "Title matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "title", "source_value": "National Sales Director - Pharmaceuticals (Infectious Disease)", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:043af6f70432ace1dc6c163b9c49f1d9:title:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.title.66fb4a1ad8c13ea5ee", "query_id": "gq_8b028d475e507d74290a", "job_id": "043af6f70432ace1dc6c163b9c49f1d9", "signal_type": "query_match", "display_text": "Title: semantic match", "tooltip": "Title provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "title", "source_value": "National Sales Director - Pharmaceuticals (Infectious Disease)", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:2a4b3b3f2e0db5473dd1b0af", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.31ece583131d3242cd", "query_id": "gq_8b028d475e507d74290a", "job_id": "043af6f70432ace1dc6c163b9c49f1d9", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer contains \"corp\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Asahi Kasei Corp.", "matched_input": "corp", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.title.5c406d305da4d63565", "query_id": "gq_8b028d475e507d74290a", "job_id": "043af6f70432ace1dc6c163b9c49f1d9", "signal_type": "query_match", "display_text": "Title: \"pharmaceuticals\"", "tooltip": "Title contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "title", "source_value": "National Sales Director - Pharmaceuticals (Infectious Disease)", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/National-Sales-Director---Pharmaceuticals--Infectious-Disease-_R5586-1", "source_values": [ "rule:remote_status" ], "checked_at": null }, "equity_included": { "tier": "inferred", "verified": false, "label": "Inferred - source not recorded", "source_label": "source not recorded", "href": null, "source_values": [], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/National-Sales-Director---Pharmaceuticals--Infectious-Disease-_R5586-1", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/National-Sales-Director---Pharmaceuticals--Infectious-Disease-_R5586-1", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "9f624d401fb691eac90d5e3467e9f1f3", "title": "Associate Director, SEC Reporting & Technical Accounting", "employer_name": "Vaxcyte Inc", "employer_slug": "vaxcyte", "location_text": "San Carlos, California, United States", "country": "US", "employment_type": "unknown", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 184000, "salary_max": 215000, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 184000, "base_salary_max": 215000, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-02-26T19:44:18.000Z", "apply_url": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Associate Director, SEC Reporting & Technical Accounting San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: The Associate Director, SEC Reporting & Technical Accounting will serve as a key contributor to the company's external reporting and technical accounting function. Reporting to the Senior Director, Technical Accounting & SEC Reporting, this role will be highly hands-on, owning the preparation and execution of SEC filings and technical", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": "2026-06-20T05:42:05.724Z", "llm_extraction_run_id": "postfix_final_004037", "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "years_min": { "field": "years_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "years_experience_min" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "base_salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "role_family": { "field": "role_family", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_family" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "company_stage": { "field": "company_stage", "source": "llm:greenfield:inv_371_postfix", "db_column": "company_stage" }, "customer_type": { "field": "customer_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "customer_type" }, "role_function": { "field": "role_function", "source": "llm:greenfield:inv_371_postfix", "db_column": "role_function" }, "salary_period": { "field": "salary_period", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_period" }, "equity_offered": { "field": "equity_offered", "source": "llm:greenfield:inv_371_postfix", "db_column": "equity_offered" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_currency": { "field": "salary_currency", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_currency" }, "salary_disclosed": { "field": "salary_disclosed", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_disclosed" }, "visa_sponsorship": { "field": "visa_sponsorship", "source": "llm:greenfield:inv_371_postfix", "db_column": "visa_sponsorship" }, "industry_vertical": { "field": "industry_vertical", "source": "llm:greenfield:inv_371_postfix", "db_column": "industry_vertical" }, "naics_sector_code": { "field": "naics_sector_code", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_code" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" }, "naics_sector_title": { "field": "naics_sector_title", "source": "llm:greenfield:inv_371_postfix", "db_column": "naics_sector_title" }, "visible_salary_max": { "field": "visible_salary_max", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_max" }, "visible_salary_min": { "field": "visible_salary_min", "source": "derived:greenfield:inv_371_postfix", "db_column": "salary_min" } }, "seniority": "director_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 10, "years_experience_max": 12, "role_function": "finance", "role_function_source": "llm:greenfield:inv_371_postfix", "company_stage": "public-company", "company_stage_source": "llm:greenfield:inv_371_postfix", "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": true, "us_citizenship_required": false, "security_clearance": "none", "education_required": "bachelors", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.title.d9b5533f645d84d944", "query_id": "gq_8b028d475e507d74290a", "job_id": "9f624d401fb691eac90d5e3467e9f1f3", "signal_type": "query_match", "display_text": "Title: semantic match", "tooltip": "Title provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "title", "source_value": "Associate Director, SEC Reporting & Technical Accounting", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:8933509c1f2519f896ef3dbc", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.792e1c27d2a72487d2", "query_id": "gq_8b028d475e507d74290a", "job_id": "9f624d401fb691eac90d5e3467e9f1f3", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "finance", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:9f624d401fb691eac90d5e3467e9f1f3:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" }, "company_stage": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5126186008?gh_jid=5126186008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": "2026-06-20T05:42:05.724Z" } } }, { "id": "de5447c941fd985f293c69416ff5f487", "title": "Director, Financial Planning & Analysis, R&D", "employer_name": "Vaxcyte Inc", "employer_slug": "vaxcyte", "location_text": "San Carlos, California, United States", "country": "US", "employment_type": "contract", "remote_status": "unspecified", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": null, "timezone_overlap_hours": 6, "salary_min": 226407, "salary_max": 264141, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "base", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": "year", "base_salary_min": 226407, "base_salary_max": 264141, "salary_disclosed": true, "equity_included": true, "equity_included_source": null, "equity_type": [ "rsu", "options", "espp" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-04-03T20:33:27.000Z", "apply_url": "https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008", "apply_url_verified": false, "ats": "greenhouse", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, Financial Planning & Analysis, R&D San Carlos, California, United States Join our Mission to Protect Humankind! Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance. WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values: *RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered. *AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind. *LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives. *MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making. Summary: This is an exciting opportunity to serve as a strategic finance business partner to Vaxcyte's R&D organization, with a focus on clinical studies. The role will support Clinical Operations and the Immunoassay and Non-Clinical teams, with responsibility for clinical trial and serology financial oversight, while flexing to support broader R&D", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 44, "benefit_verified": true, "benefit_last_verified": "2026-06-13T01:18:42.546Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_max": { "field": "salary_max", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_max" }, "salary_min": { "field": "salary_min", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_min" }, "equity_type": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "role_function": { "field": "role_function", "source": "rule", "db_column": "role_function" }, "employment_type": { "field": "employment_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "employment_type" }, "equity_included": { "source": "sec_10k", "source_url": "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm", "source_fields": [ "equity_offered", "equity_type" ] }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "finance", "role_function_source": "rule", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 55, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.title.e81d647ad694f64335", "query_id": "gq_8b028d475e507d74290a", "job_id": "de5447c941fd985f293c69416ff5f487", "signal_type": "query_match", "display_text": "Title: semantic match", "tooltip": "Title provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "title", "source_value": "Director, Financial Planning & Analysis, R&D", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:0ffe56dec01882f4cfd3b8fa", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.role_function.20af53c2293bbd984e", "query_id": "gq_8b028d475e507d74290a", "job_id": "de5447c941fd985f293c69416ff5f487", "signal_type": "query_match", "display_text": "Role: semantic match", "tooltip": "Role provided semantic evidence for your search intent.", "source_binding": "vector_semantic_evidence", "source_field": "role_function", "source_value": "finance", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:de5447c941fd985f293c69416ff5f487:vector", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 74, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "salary_min": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_max": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "salary_type": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "equity_included": { "tier": "government", "verified": true, "label": "Verified - SEC 10-K", "source_label": "SEC 10-K", "href": "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm", "source_values": [ "sec_10k", "https://www.sec.gov/Archives/edgar/data/1649094/000164909426000007/pcvx-20251231.htm" ], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-13T01:18:42.546Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null }, "role_function": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://boards.greenhouse.io/vaxcyte/jobs/5173368008?gh_jid=5173368008", "source_values": [ "rule" ], "checked_at": null } } }, { "id": "6622eb138a7ec13b2826568c5b1a1a0a", "title": "Director, National Accounts - Pharmaceuticals", "employer_name": "Asahi Kasei Corp.", "employer_slug": "asahi-kasei", "location_text": "Remote Home Office USA", "country": "US", "employment_type": "unknown", "remote_status": "remote", "remote_status_source": null, "remote_status_enriched_at": null, "days_in_office": 0, "timezone_overlap_hours": 6, "salary_min": null, "salary_max": null, "salary_min_source": null, "salary_max_source": null, "salary_currency": "USD", "salary_type": "unknown", "salary_type_source": null, "salary_type_enriched_at": null, "salary_period": null, "base_salary_min": null, "base_salary_max": null, "salary_disclosed": false, "equity_included": false, "equity_included_source": null, "equity_type": [ "none" ], "k401_match": "yes", "match_401k_pct": null, "match_401k_pct_source": null, "k401_match_source_url": null, "k401_match_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "k401_contribution_source_url": null, "k401_contribution_source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "profit_sharing": false, "bonus_offered": false, "mental_health_support": null, "childcare_subsidy": null, "fertility_family_building_benefits": null, "adoption_assistance_offered": null, "surrogacy_assistance_offered": null, "student_loan_repayment_offered": null, "learning_budget_offered": null, "relocation_assistance": null, "top_startup_sources": [], "posted_at": "2026-05-12T00:00:00.000Z", "apply_url": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/Director--National-Accounts---Pharmaceuticals_R5545-1", "apply_url_verified": false, "ats": "workday", "url_last_checked_alive": null, "removed_at": null, "description_excerpt": "Director, National Accounts - Pharmaceuticals Remote Home Office USA posted: Posted 30+ Days Ago", "parental_leave_weeks": null, "non_birth_parent_leave_weeks": null, "parental_leave_weeks_source": null, "non_birth_parent_leave_weeks_source": null, "parental_leave_source_url": null, "pto_days": null, "unlimited_pto": false, "sabbatical_eligible": false, "family_friendly_score": 48, "benefit_verified": true, "benefit_last_verified": "2026-06-07T00:00:00Z", "hire_states_allowed": [], "state_eligibility_source": null, "state_eligibility_enriched_at": null, "llm_quality_pass_at": null, "llm_signals_at": null, "llm_extraction_run_id": null, "llm_extraction_extracted_at": null, "llm_extraction_field_sources": { "seniority": { "field": "seniority", "source": "llm:greenfield:inv_371_postfix", "db_column": "seniority" }, "k401_match": { "source": "dol_form_5500", "source_url": null, "source_fields": [ "EMPLR_CONTRIB_INCOME_AMT" ], "source_label": "DOL Form 5500 filing" }, "salary_type": { "field": "salary_type", "source": "llm:greenfield:inv_371_postfix", "db_column": "salary_type" }, "remote_status": { "field": "remote_status", "source": "rule:remote_status", "db_column": "remote_status" }, "days_in_office": { "field": "days_in_office", "source": "rule:remote_status", "db_column": "days_in_office" }, "education_required": { "field": "education_required", "source": "llm:greenfield:inv_371_postfix", "db_column": "education_required" } }, "seniority": "staff_plus", "seniority_source": "llm:greenfield:inv_371_postfix", "years_experience_min": 8, "years_experience_max": 12, "role_function": "other", "role_function_source": "unknown", "company_stage": null, "company_stage_source": null, "employer_industry": null, "employer_industry_source": null, "employer_size": null, "quality_score": 35, "travel_pct": null, "requires_shift": null, "shift_type": "unknown", "shift_type_source": null, "weekend_work": "unknown", "weekend_work_source": null, "relocation_assistance_source": null, "contractor_w2": "unknown", "required_timezone": null, "fertility_family_building_benefits_source": null, "mental_health_support_source": null, "adoption_assistance_offered_source": null, "childcare_subsidy_source": null, "learning_budget_offered_source": null, "surrogacy_assistance_offered_source": null, "cover_letter_required": null, "cover_letter_required_source": null, "assessment_required": null, "assessment_required_source": null, "application_deadline": null, "application_deadline_source": null, "visa_sponsorship": false, "us_citizenship_required": false, "security_clearance": "none", "education_required": "none", "roll_up_count": null, "roll_up_total_locations": null, "explanations": [ { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.description_excerpt.5ebe4bfb793934b0de", "query_id": "gq_8b028d475e507d74290a", "job_id": "6622eb138a7ec13b2826568c5b1a1a0a", "signal_type": "query_match", "display_text": "Description: \"pharmaceuticals\"", "tooltip": "Description matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "description_excerpt", "source_value": "Director, National Accounts - Pharmaceuticals Remote Home Office USA posted: Posted 30+ Days Ago", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6622eb138a7ec13b2826568c5b1a1a0a:description:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.d9e3a4e5e1b965720e", "query_id": "gq_8b028d475e507d74290a", "job_id": "6622eb138a7ec13b2826568c5b1a1a0a", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer matched \"corp\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "employer_name", "source_value": "Asahi Kasei Corp.", "matched_input": "corp", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6622eb138a7ec13b2826568c5b1a1a0a:employer:corp", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.title.47c74ce51a81536760", "query_id": "gq_8b028d475e507d74290a", "job_id": "6622eb138a7ec13b2826568c5b1a1a0a", "signal_type": "query_match", "display_text": "Title: \"pharmaceuticals\"", "tooltip": "Title matched \"pharmaceuticals\" from your search.", "source_binding": "bm25_field_evidence", "source_field": "title", "source_value": "Director, National Accounts - Pharmaceuticals", "matched_input": "pharmaceuticals", "derivation_source": "candidate_result.raw_match_evidence", "candidate_evidence_id": "ev:gq_8b028d475e507d74290a:6622eb138a7ec13b2826568c5b1a1a0a:title:pharmaceuticals", "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "candidate_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 90, "mobile_priority": 1, "ui": { "icon": "Search", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.semantic.title.cf6f614bd7cdd85407", "query_id": "gq_8b028d475e507d74290a", "job_id": "6622eb138a7ec13b2826568c5b1a1a0a", "signal_type": "query_match", "display_text": "Title: semantic match", "tooltip": "Title provided semantic evidence for your search intent.", "source_binding": "reranker_semantic_evidence", "source_field": "title", "source_value": "Director, National Accounts - Pharmaceuticals", "matched_input": "tonix pharmaceuticals holding corp", "derivation_source": "rerank_result.semantic_evidence", "candidate_evidence_id": null, "rerank_evidence_id": "rerank:fdaa3cd62ffd1fae90e23ed5", "taxonomy_alias_id": null, "oracle_verification_method": "reranker_evidence_exists", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": false, "priority": 86, "mobile_priority": 2, "ui": { "icon": "Sparkles", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.employer_name.6489c5b1f206b1a4c0", "query_id": "gq_8b028d475e507d74290a", "job_id": "6622eb138a7ec13b2826568c5b1a1a0a", "signal_type": "query_match", "display_text": "Employer: \"corp\"", "tooltip": "Employer contains \"corp\" from your search.", "source_binding": "token_match", "source_field": "employer_name", "source_value": "Asahi Kasei Corp.", "matched_input": "corp", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } }, { "schema_version": "inv382.match_signal.v1", "signal_id": "sig.query.title.8ce247d6d13ac22db4", "query_id": "gq_8b028d475e507d74290a", "job_id": "6622eb138a7ec13b2826568c5b1a1a0a", "signal_type": "query_match", "display_text": "Title: \"pharmaceuticals\"", "tooltip": "Title contains \"pharmaceuticals\" from your search.", "source_binding": "token_match", "source_field": "title", "source_value": "Director, National Accounts - Pharmaceuticals", "matched_input": "pharmaceuticals", "derivation_source": "row_field", "candidate_evidence_id": null, "rerank_evidence_id": null, "taxonomy_alias_id": null, "oracle_verification_method": "row_field_contains", "counts_for_non_trivial_query": true, "truth_verified": true, "exact": true, "priority": 80, "mobile_priority": 2, "ui": { "icon": "SearchCheck", "tone": "match", "href": null } } ], "source_label": "DOL Form 5500 filing", "parental_leave_source_label": null, "k401_match_source_label": "DOL Form 5500 filing", "k401_contribution_source_label": "DOL Form 5500 filing", "apply_url_checked_at": null, "apply_url_verification_status": "not_reachable_or_not_checked", "apply_url_verification_label": "Not checked or not reachable at last crawl", "field_source_signals": { "remote_status": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/Director--National-Accounts---Pharmaceuticals_R5545-1", "source_values": [ "rule:remote_status" ], "checked_at": null }, "equity_included": { "tier": "inferred", "verified": false, "label": "Inferred - source not recorded", "source_label": "source not recorded", "href": null, "source_values": [], "checked_at": null }, "k401_match": { "tier": "government", "verified": true, "label": "Verified - DOL Form 5500", "source_label": "DOL Form 5500", "href": null, "source_values": [ "dol_form_5500", "EMPLR_CONTRIB_INCOME_AMT" ], "checked_at": "2026-06-07T00:00:00Z" }, "seniority": { "tier": "posting", "verified": true, "label": "From the posting", "source_label": "the posting", "href": "https://akamerica.wd501.myworkdayjobs.com/aka/job/Remote-Home-Office-USA/Director--National-Accounts---Pharmaceuticals_R5545-1", "source_values": [ "llm:greenfield:inv_371_postfix" ], "checked_at": null } } } ], "total": 17, "page": 1, "per_page": 24, "applied_filters": { "q": "Tonix Pharmaceuticals Holding Corp" }, "hidden_unknown_benefits_count": 0, "hidden_quality_floor_count": 0, "quality_floor": "default", "search_profile": { "profile_id": "inv382.d6.pg_textsearch_bge_small_rrf.v1", "bm25_extension": "pg_textsearch", "vector_model": "BAAI/bge-small-en-v1.5", "vector_model_version": "v1.5", "fusion_method": "rrf" }, "explanation_context": { "non_trivial_query": true, "query_terms": [ "tonix", "pharmaceuticals", "holding", "corp" ], "active_filter_keys": [], "visible_signal_limit": 3, "visible_trust_limit": 2 }, "event_context": { "query_context": { "query_id": "1f418ca4-d768-4135-a408-ed3d03dc4cc4", "issued_at": "2026-08-11T20:50:10.807Z", "route": "/jobs", "page": 1, "per_page": 24, "total_results": 17, "sort": "relevance", "ranking_policy": "hybrid_rrf_rerank", "ranking_policy_version": "inv382.jobs.search.v2", "query_hash": "hmac_sha256:Ejl6ZrimJzGbNtMumnxZCyGRKV08F4w3x8maGsEU_T0", "filter_hash": "hmac_sha256:6CBErDPXOFVCSNkSGbTmuw6GxoMjwSLro0KqZMtxL_0", "query_features": { "has_q": true, "q_term_count": 4, "q_length_bucket": "16_40", "q_pii_redacted": false, "state_count": 0, "benefit_filters": [], "quality_floor": "default" }, "exposures": [ { "result_id": "d9dd77bba2763c86b4e97f912ac69625", "position": 1, "page_position": 1, "retrieval_features": { "bm25_score": -27.962738752365112, "vector_score": 0.19941434858484075, "rrf_score": 0.027799227799227798, "rerank_score": 9.457108497619629, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 159, "quality_score": 55 } }, { "result_id": "dead2e586561377764f2a1fe30e9a500", "position": 2, "page_position": 2, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.2015608549118042, "rrf_score": 0.027777777777777776, "rerank_score": 9.43676471710205, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 208, "quality_score": 55 } }, { "result_id": "f0ce14bd47d44c234dc4d1bfb2dda4fa", "position": 3, "page_position": 3, "retrieval_features": { "bm25_score": -28.616620540618896, "vector_score": 0.23341405391693115, "rrf_score": 0.029116045245077504, "rerank_score": 9.280496597290039, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 85, "quality_score": 55 } }, { "result_id": "68bb3e89493f97efe7d4b0ce5fd3e5e1", "position": 4, "page_position": 4, "retrieval_features": { "bm25_score": -27.962738752365112, "vector_score": 0.2136002310276155, "rrf_score": 0.027212143650499815, "rerank_score": 9.279154777526855, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 131, "quality_score": 55 } }, { "result_id": "a771ce567d3aa976d8a681c6f9939324", "position": 5, "page_position": 5, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.21774053573608398, "rrf_score": 0.027417840375586856, "rerank_score": 9.209918022155762, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 180, "quality_score": 55 } }, { "result_id": "3c24ac7bb567169977728f315265cb92", "position": 6, "page_position": 6, "retrieval_features": { "bm25_score": -27.54427409172058, "vector_score": 0.1978490948677063, "rrf_score": 0.027692895339954164, "rerank_score": 9.02929973602295, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 119, "quality_score": 55 } }, { "result_id": "43c521ed362b3cbb500a34ca41435de7", "position": 7, "page_position": 7, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.19292205572128296, "rrf_score": 0.03007688828584351, "rerank_score": 9.021228790283203, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 109, "quality_score": 55 } }, { "result_id": "19f128092c2078d54205dc1b98eb6237", "position": 8, "page_position": 8, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.1977318407456955, "rrf_score": 0.03055037313432836, "rerank_score": 8.946955680847168, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 98, "quality_score": 55 } }, { "result_id": "076f9f44f246f0b540e082f0b12e48b8", "position": 9, "page_position": 9, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.1917194128036499, "rrf_score": 0.03125763125763126, "rerank_score": 8.933963775634766, "text_match_title": true, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 68, "quality_score": 55 } }, { "result_id": "1b326dea67a7a33623858526b1b4d5b5", "position": 10, "page_position": 10, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.189896918547515, "rrf_score": 0.03125763125763126, "rerank_score": 8.91891098022461, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 120, "quality_score": 55 } }, { "result_id": "6445f086c535ac6e27d289212fcec87f", "position": 11, "page_position": 11, "retrieval_features": { "bm25_score": -28.616620540618896, "vector_score": 0.2207683789272069, "rrf_score": 0.029551337359792925, "rerank_score": 8.85533332824707, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 85, "quality_score": 55 } }, { "result_id": "22eb7400d93a2228a5baebd96c302a3f", "position": 12, "page_position": 12, "retrieval_features": { "bm25_score": -27.54427409172058, "vector_score": 0.20834332704544067, "rrf_score": 0.026856524873828405, "rerank_score": 8.852707862854004, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 82, "quality_score": 55 } }, { "result_id": "f06685f8e74b0dfbf35a29a875ace009", "position": 13, "page_position": 13, "retrieval_features": { "bm25_score": -27.962738752365112, "vector_score": 0.19099438190460205, "rrf_score": 0.028958333333333336, "rerank_score": 8.84078598022461, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 144, "quality_score": 55 } }, { "result_id": "256f7ef8e33d2e98558295760474e478", "position": 14, "page_position": 14, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.1869598627090454, "rrf_score": 0.031544957774465976, "rerank_score": 8.803912162780762, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 159, "quality_score": 55 } }, { "result_id": "5c6b235f210f6bca2c418a52d210c197", "position": 15, "page_position": 15, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.18842260906561414, "rrf_score": 0.030834914611005692, "rerank_score": 8.747550010681152, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 239, "quality_score": 55 } }, { "result_id": "7889073eeed97ffb0af8f3c7a5a54399", "position": 16, "page_position": 16, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.20070449105447075, "rrf_score": 0.028577260665441927, "rerank_score": 8.63387393951416, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 202, "quality_score": 55 } }, { "result_id": "79078570025ba379266174208ccd6737", "position": 17, "page_position": 17, "retrieval_features": { "bm25_score": -28.216046810150146, "vector_score": 0.19910821912015098, "rrf_score": 0.02877846790890269, "rerank_score": 8.133853912353516, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 153, "quality_score": 55 } }, { "result_id": "a0435b45c52a184adae206b9577d6328", "position": 18, "page_position": 18, "retrieval_features": { "bm25_score": 0, "vector_score": 0.3200768232345581, "rrf_score": 0.01282051282051282, "rerank_score": -2.783989429473877, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 77, "quality_score": 55 } }, { "result_id": "5602c1f6ba651a74f09c99cb06b17a0a", "position": 19, "page_position": 19, "retrieval_features": { "bm25_score": 0, "vector_score": 0.3209406542217329, "rrf_score": 0.012658227848101266, "rerank_score": -3.2106499671936035, "text_match_title": false, "text_match_employer": true, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 90, "quality_score": 55 } }, { "result_id": "8e771fd18cfcd3e69fa10b9e491e5693", "position": 20, "page_position": 20, "retrieval_features": { "bm25_score": -11.914462089538574, "vector_score": 0, "rrf_score": 0.012048192771084338, "rerank_score": -5.566384315490723, "text_match_title": false, "text_match_employer": true, "role_match": false, "benefit_verified": false, "salary_disclosed": false, "posted_age_days": 179, "quality_score": 45 } }, { "result_id": "043af6f70432ace1dc6c163b9c49f1d9", "position": 21, "page_position": 21, "retrieval_features": { "bm25_score": -12.60332727432251, "vector_score": 0, "rrf_score": 0.0125, "rerank_score": -6.633657455444336, "text_match_title": true, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 76, "quality_score": 35 } }, { "result_id": "9f624d401fb691eac90d5e3467e9f1f3", "position": 22, "page_position": 22, "retrieval_features": { "bm25_score": 0, "vector_score": 0.3225861384025882, "rrf_score": 0.012195121951219513, "rerank_score": -6.745408535003662, "text_match_title": true, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 166, "quality_score": 55 } }, { "result_id": "de5447c941fd985f293c69416ff5f487", "position": 23, "page_position": 23, "retrieval_features": { "bm25_score": 0, "vector_score": 0.32568228244781494, "rrf_score": 0.012048192771084338, "rerank_score": -7.051624774932861, "text_match_title": true, "text_match_employer": false, "role_match": true, "benefit_verified": true, "salary_disclosed": true, "posted_age_days": 130, "quality_score": 55 } }, { "result_id": "6622eb138a7ec13b2826568c5b1a1a0a", "position": 24, "page_position": 24, "retrieval_features": { "bm25_score": -12.886427402496338, "vector_score": 0, "rrf_score": 0.012658227848101266, "rerank_score": -7.827968597412109, "text_match_title": true, "text_match_employer": true, "role_match": false, "benefit_verified": true, "salary_disclosed": false, "posted_age_days": 91, "quality_score": 35 } } ] }, "context_signature": "_so55wXZJRRtlNXh8hnfOOwsDx6OGY2-PELadtmppqU", "event_token": "_so55wXZJRRtlNXh8hnfOOwsDx6OGY2-PELadtmppqU" } }